Role of pippalyadi anjana And Triphala Rasayana in first stage of cataract

Phase 1

Not yet recruiting

• Conditions: Unspecified age-related cataract,

• Registration Number: CTRI/2020/04/024668
• Lead Sponsor: Rishikul campus UAU Harrawala Dehradun

Brief Summary

Globally, WHO has identified cataract as a first most common cause of preventable blindness among five major blinding eye conditions.Senile cataract is one of the major causes for the age related visual impairment and blindness. In India,there is 50-80% of bilateral blindness is due to cataract. Lack of established conservative treatment for senile cataract evoked the necessity to find an option through treatment modalities in the management. In ayurvedic classics, among various treatment modalities anjana is the foremost procedure which drains out doshas from vartmagat siras,srotas and shringataka marma through mouth, nostrils and eyes.As this is a senile disease swabhav balpravritta vyadhi So, in this aspect orally  Rasayana  is given  which is  rejuvenating, nutritious and possess strong antioxidant activity.Considering all these facts, the pippalyadi anjana and triphala rasayana both from yogratnakar has been selected for the present study.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-20
• Last Update Posted: 2020-11-04

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• 1.6/9-6/60 with best corrected visual acuity.
• 2.patient having sign and symptoms of pratham,dwitiya and tritiya patalagata timira 3.Stage of immature cataract.

Exclusion Criteria

• 1.patient less than 45 years and more than 70 years.
• 2.Less than 6/60 with best corrected visual acuity.
• 3.patient having signs and symptoms of mature and hyper mature cataract.
• 4.Known case of congenital,developmental,traumatic,complicated and metabolic cataract.
• 5.patient associated with Hypertension and diabetes mellitus.
• 6.patient under chemotherapy, steroids and immunosuppressive drugs therapy 7.known case of uvietis,glaucoma and retinopathies.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Delay the progression of senile cataract	2 months

Secondary Outcome Measures

Name	Time	Method
Relief in the associated symptoms of senile cataract	2 months

Trial Locations

Locations (1)

Rishikul Campus Uttarakhand Ayurved University; 🇮🇳 Hardwar, UTTARANCHAL, India

Rishikul Campus Uttarakhand Ayurved University

🇮🇳Hardwar, UTTARANCHAL, India

Akanksha Singh

Principal investigator

7895045785

akanksha0729@gmail.com